Medeva BV v Comptroller General of Patents, Designs and Trade Marks.

Core Citations

WORK EXPRESSION OF in

• Medeva BV v Comptroller General of Patents, Designs and Trade Marks.

This document cites

• AHP Manufacturing BV v Bureau voor de Industriële Eigendom.
• Reino de España contra Consejo de la Unión Europea.
• Société Pipeline Méditerranée et Rhône (SPMR) v Administration des douanes et droits indirects and Direction nationale du renseignement et des enquêtes douanières (DNRED).
• Hässle AB v Ratiopharm GmbH.
• Biogen Inc. contra Smithkline Beecham Biologicals SA.



See all quotations

• The Queen v Commissioners of Customs and Excise, ex parte EMU Tabac SARL, The Man in Black Ltd, John Cunningham.
• Novartis AG, University College London and Institute of Microbiology and Epidemiology v Comptroller-General of Patents, Designs and Trade Marks for the United Kingdom (C-207/03) and Ministre de l'Économie v Millennium Pharmaceuticals Inc. (C-252/03).
• Kirin Amgen Inc. v Lietuvos Respublikos valstybinis patentų biuras.
• Commission of the European Communities v Federal Republic of Germany.
• Farmitalia Carlo Erba Srl.
• Massachusetts Institute of Technology.
• Yissum Research and Development Company of the Hebrew University of Jerusalem v Comptroller-General of Patents.
• Council Regulation (EEC) No 1768/92 of 18 June 1992 concerning the creation of a supplementary protection certificate for medicinal products
• Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use
• Regulation (EC) No 469/2009 of the European Parliament and of the Council of 6 May 2009 concerning the supplementary protection certificate for medicinal products (Codified version) (Text with EEA relevance)
• Directive 2001/82/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to veterinary medicinal products